The use of intravitreal (IVT) corticosteroids for treatment of posterior segment diseases has
increased significantly over the last decade. A commonly recognized complication of IVT …

Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years.
Its use has increased dramatically in recent years for periocular and intraocular treatment of …

Background: Based on experimental studies and clinical observations by Robert Machemer,
Gholam Peyman and others, the vitreous cavity has increasingly been used as a reservoir of …

PURPOSE: To evaluate complications and results of intravitreal triamcinolone acetonide for
treatment of macular edema. DESIGN: Interventional, consecutive, retrospective case series …

Intravitreal triamcinolone acetonide (IVTA) has increasingly been applied as treatment for
various intraocular neovascular and oedematous diseases. Comparing the various diseases …

Loss of blood-retinal barrier (BRB) integrity and vascular permeability characterizes diabetic
retinopathy, and new therapies to reverse or prevent vascular permeability are needed to …

OBJECTIVE: To evaluate the efficacy of sequential intravitreal triamcinolone acetonide (TA)
injection followed by grid laser photocoagulation for treating diabetic macular edema (DME) …

Purpose: To achieve a safer alternative to intravitreal injection of corticosteroids, we
developed and characterized triamcinolone acetonide-loaded liposomes formulations (TA …

Diabetic macular edema (DME) is a major ocular complication of diabetes mellitus (DM),
leading to significant visual impairment. DME's pathogenesis is multifactorial. Focal edema …

Tight junctions between vascular endothelial cells help to create the blood–brain and blood–
retinal barriers. Breakdown of the retinal tight junction complex is problematic in several …